Your browser doesn't support javascript.
loading
Clinical characteristics of heart failure with reduced ejection fraction patients with rare pathogenic variants in dilated cardiomyopathy-associated genes: A subgroup analysis of the PARADIGM-HF trial.
Barat, Ana; Chen, Chien-Wei; Patel-Murray, Natasha; McMurray, John J V; Packer, Milton; Solomon, Scott D; Desai, Akshay S; Rouleau, Jean L; Zile, Michael R; Attari, Zenab; Zhang, Cong; Xu, Huilei; Hartman, Nicole; Hon, Claudia; Healey, Margaret; Chutkow, William; O'Donnell, Christopher J; Jacob, Jaison; Lefkowitz, Marty; Mendelson, Michael M; Wandel, Simon; Yates, Denise; Gimpelewicz, Claudio.
Afiliación
  • Barat A; Novartis Ireland Ltd, Dublin, Ireland.
  • Chen CW; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Patel-Murray N; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • McMurray JJV; University of Glasgow, BHF Cardiovascular Research Centre, Glasgow, UK.
  • Packer M; Baylor University Medical Center, Baylor Heart and Vascular Institute, Dallas, TX, USA.
  • Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
  • Desai AS; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
  • Rouleau JL; Institut de Cardiologie de Montréal, Université de Montréal, Montreal, Quebec, Canada.
  • Zile MR; Medical University of South Carolina, Charleston, SC, USA.
  • Attari Z; Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston, SC, USA.
  • Zhang C; Global Development Operations, Novartis, Hyderabad, India.
  • Xu H; Novartis Institutes for Biomedical Research, Shanghai, China.
  • Hartman N; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Hon C; Novartis Pharma AG, Basel, Switzerland.
  • Healey M; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Chutkow W; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • O'Donnell CJ; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Jacob J; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Lefkowitz M; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Mendelson MM; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Wandel S; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
  • Yates D; Novartis Pharma AG, Basel, Switzerland.
  • Gimpelewicz C; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
Eur J Heart Fail ; 25(8): 1256-1266, 2023 08.
Article en En | MEDLINE | ID: mdl-37191081
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cardiomiopatía Dilatada / Insuficiencia Cardíaca Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Heart Fail Asunto de la revista: CARDIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Irlanda Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cardiomiopatía Dilatada / Insuficiencia Cardíaca Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Heart Fail Asunto de la revista: CARDIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Irlanda Pais de publicación: Reino Unido